Weighted lottery to equitably allocate scarce supply of COVID-19 monoclonal antibody
About The Study: The results of this study suggest that a weighted lottery to allocate scarce resources is feasible and may ...
Tag: monoclonal
AGS supports CMS decision to require real-world data for monoclonal antibodies
New York (July 11, 2023) — The American Geriatrics Society (AGS) supports the recently announced decision from the Centers for Medicare ...
Neutralizing monoclonal antibody use and COVID-19 infection outcomes
About The Study: In this study that included 167,000 non-hospitalized patients, neutralizing monoclonal antibody (nMAb) treatment for COVID-19 was safe and ...
First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases
In a pilot trial and clinical sample-based investigations, the drug Foralumab decreased inflammatory markers in patients with COVID-19 Similar reduction ...
Addition of antioxidants to cell cultures can enhance the production of monoclonal antibodies, promising therapeutics for a range of health conditions
Researchers at the Department of Chemical Engineering, Indian Institute of Technology, India, have investigated the effects of oxidative stress on ...
Administration of anti–SARS-CoV-2 monoclonal antibodies after FDA deauthorization
About The Study: Hospitals and health systems administered more than 158,000 anti–SARS-CoV-2 monoclonal antibodies (mAbs) doses in early 2022 despite Food ...
Monoclonal antibody reduces asthma attacks in urban youth
A monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form ...
ACTG announces publication of ACTIV-2 study in Cell Reports Medicine demonstrating rapid clearance of culturable SARS-CoV-2 following monoclonal antibody treatment
Los Angeles, Calif. – The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded to conduct ...
Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants
BIRMINGHAM, Ala. – The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability ...
COVID-19: Identification of broadly SARS-CoV-2 neutralizing monoclonal antibodies
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised ...
NIH launches trial of monoclonal antibody to treat asthma in urban youth
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks ...
Association of injection or IV administration of monoclonal antibodies with COVID-19 outcomes
What The Study Did: Researchers evaluated whether receiving by injection the monoclonal antibodies casirivimab and imdevimab was associated with reduced ...
Alzheimer’s Association comment on Medicare coverage policy for monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease
CHICAGO, April 7, 2022 — “We are currently reviewing the CMS final decision. At initial review we are very disappointed ...
Those at highest risk for severe COVID-19 often least likely to get monoclonal antibodies
Boston, MA – People over age 65 at the highest risk for severe COVID-19 have often been the least likely ...
COVID-19 – Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to ...
-
Null results research now published by major behavioral medicine journal
-
New findings on hair loss in men
-
Tirzepatide more effective in blood sugar control and body weight loss than semaglutide, shows meta-analysis of 22 studies
-
Astronomers discover newborn galaxies with the James Webb Space Telescope
-
Chromosome-scale genome sequence of Suaeda glauca sheds light on salt stress tolerance in halophytes
-
ISSCR Kicks off São Paulo International Symposium today in Ribeirão Preto, Brazil